These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17236113)

  • 1. Methylsulfonylmethane (MSM) ingestion causes a significant resonance in proton magnetic resonance spectra of brain and cerebrospinal fluid.
    Willemsen MA; Engelke UF; van der Graaf M; Wevers RA
    Neuropediatrics; 2006 Oct; 37(5):312-4. PubMed ID: 17236113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation.
    Cecil KM; Lin A; Ross BD; Egelhoff JC
    J Comput Assist Tomogr; 2002; 26(5):818-20. PubMed ID: 12439321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy.
    Rose SE; Chalk JB; Galloway GJ; Doddrell DM
    Magn Reson Imaging; 2000 Jan; 18(1):95-8. PubMed ID: 10642107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.
    Butawan M; Benjamin RL; Bloomer RJ
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy.
    Zhang M; Wong IG; Gin JB; Ansari NH
    Drug Deliv; 2009 Jul; 16(5):243-8. PubMed ID: 19538004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR.
    Engelke UF; Tangerman A; Willemsen MA; Moskau D; Loss S; Mudd SH; Wevers RA
    NMR Biomed; 2005 Aug; 18(5):331-6. PubMed ID: 15996001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylsulfonylmethane (MSM): A chemical shift reference for
    Kaiser LG; Russell D; Maschmeyer T; Redfern RL; Inglis BA
    Magn Reson Med; 2020 Apr; 83(4):1157-1167. PubMed ID: 31566256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and distribution of [35S]methylsulfonylmethane following oral administration to rats.
    Magnuson BA; Appleton J; Ames GB
    J Agric Food Chem; 2007 Feb; 55(3):1033-8. PubMed ID: 17263509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy.
    Lin A; Nguy CH; Shic F; Ross BD
    Toxicol Lett; 2001 Sep; 123(2-3):169-77. PubMed ID: 11641045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High resolution NMR spectroscopy of CSF: methodological issues and perspective clinical applications].
    Kriat M; Nicoli F; Vion-Dury J; Confort-Gouny S; Dano P; Grisoli F; Gastaut JL; Cozzone PJ
    Ann Biol Clin (Paris); 1991; 49(9):461-7. PubMed ID: 1789500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers.
    Liu X; Hunter DJ; Eyles J; McLachlan AJ; Adiwidjaja J; Eagles SK; Wang X
    J Pharm Pharmacol; 2020 Jan; 72(1):121-131. PubMed ID: 31608447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidinoacetate methyltransferase (GAMT) deficiency diagnosed by proton NMR spectroscopy of body fluids.
    Engelke UF; Tassini M; Hayek J; de Vries M; Bilos A; Vivi A; Valensin G; Buoni S; Zannolli R; Brussel W; Kremer B; Salomons GS; Veendrick-Meekes MJ; Kluijtmans LA; Morava E; Wevers RA
    NMR Biomed; 2009 Jun; 22(5):538-44. PubMed ID: 19288536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain, skull, and cerebrospinal fluid volumes in adult posttraumatic stress disorder.
    Woodward SH; Kaloupek DG; Streeter CC; Kimble MO; Reiss AL; Eliez S; Wald LL; Renshaw PF; Frederick BB; Lane B; Sheikh JI; Stegman WK; Kutter CJ; Stewart LP; Prestel RS; Arsenault NJ
    J Trauma Stress; 2007 Oct; 20(5):763-74. PubMed ID: 17955544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the way, doctor. Is MSM as good as it sounds? Can you tell me anything about the dietary supplement MSM? I've heard it's supposed to relieve arthritis pain.
    Robb-Nicholson C
    Harv Womens Health Watch; 2002 Aug; 9(12):8. PubMed ID: 12370155
    [No Abstract]   [Full Text] [Related]  

  • 17. Region-dependent alterations in glutamate and GABA measured by high-resolution magnetic resonance spectroscopy following acute binge inhalation of toluene in juvenile rats.
    O'Leary-Moore SK; Galloway MP; McMechan AP; Hannigan JH; Bowen SE
    Neurotoxicol Teratol; 2007; 29(4):466-75. PubMed ID: 17466488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation.
    Berardesca E; Cameli N; Cavallotti C; Levy JL; Piérard GE; de Paoli Ambrosi G
    J Cosmet Dermatol; 2008 Mar; 7(1):8-14. PubMed ID: 18254805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of analyte concentration using the residual solvent resonance in (1)H NMR spectroscopy.
    Pierens GK; Carroll AR; Davis RA; Palframan ME; Quinn RJ
    J Nat Prod; 2008 May; 71(5):810-3. PubMed ID: 18393462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.